APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Selected research

Industry Growth & Trends

Global Inhaled Nitric Oxide Industry Growth and Trends Forecast to 2032

Report ID 174002900126 December 202579 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

Read the full market overview

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

Report Scope

This report provides a structured, data-driven view of the global Inhaled Nitric Oxide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhaled Nitric Oxide market size, estimates, and forecasts are presented in terms of sales volume (M L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhaled Nitric Oxide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhaled Nitric Oxide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhaled Nitric Oxide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhaled Nitric Oxide Market by Company

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Inhaled Nitric Oxide Segment by Type

800 ppm

100 ppm

Others

Inhaled Nitric Oxide Segment by Application

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

Inhaled Nitric Oxide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhaled Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 800 ppm Table 2. Major Company of 100 ppm Table 3. Major Company of Others Table 4. Global Inhaled Nitric Oxide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 6. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2021-2026) Table 9. Global Inhaled Nitric Oxide Price by Type (2021-2026) & (US$/L) Table 10. Global Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 11. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Inhaled Nitric Oxide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2027-2032) Table 14. Global Inhaled Nitric Oxide Price by Type (2027-2032) & (US$/L) Table 15. North America Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 16. North America Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 18. Europe Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 20. Asia-Pacific Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 22. Latin America Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 24. Middle East and Africa Inhaled Nitric Oxide Sales by Type (2021-2026) & (US$ Million) Table 25. Inhaled Nitric Oxide Industry Trends Table 26. Inhaled Nitric Oxide Industry Drivers Table 27. Inhaled Nitric Oxide Industry Opportunities and Challenges Table 28. Inhaled Nitric Oxide Industry Restraints Table 29. Global Inhaled Nitric Oxide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Inhaled Nitric Oxide Revenue Market Share by Company (2021-2026) Table 31. Global Inhaled Nitric Oxide Sales by Company (2021-2026) & (M L) Table 32. Global Inhaled Nitric Oxide Sales Share by Company (2021-2026) Table 33. Global Inhaled Nitric Oxide Market Price by Company (2021-2026) & (US$/L) Table 34. Global Inhaled Nitric Oxide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Inhaled Nitric Oxide Major Company Production Sites and Headquarters Table 36. Global Inhaled Nitric Oxide Company, Product Type & Application Table 37. Global Inhaled Nitric Oxide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Inhaled Nitric Oxide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Inhaled Nitric Oxide Sales by Region (2021-2026) & (M L) Table 42. Global Inhaled Nitric Oxide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Inhaled Nitric Oxide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Inhaled Nitric Oxide Sales Market Share in Value by Region (2021-2026) Table 45. Global Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 46. Global Inhaled Nitric Oxide Sales by Region (2027-2032) & (M L) Table 47. Global Inhaled Nitric Oxide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Inhaled Nitric Oxide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Inhaled Nitric Oxide Sales Market Share in Value by Region (2027-2032) Table 50. Global Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 51. Global Inhaled Nitric Oxide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 53. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2021-2026) Table 56. Global Inhaled Nitric Oxide Price by Application (2021-2026) & (US$/L) Table 57. Global Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 58. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Inhaled Nitric Oxide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2027-2032) Table 61. Global Inhaled Nitric Oxide Price by Application (2027-2032) & (US$/L) Table 62. North America Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 63. North America Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 65. Europe Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 67. Asia-Pacific Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 69. Latin America Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 71. Middle East and Africa Inhaled Nitric Oxide Sales by Application (2021-2026) & (US$ Million) Table 72. Mallinckrodt Company Information Table 73. Mallinckrodt Business Overview Table 74. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 75. Mallinckrodt Inhaled Nitric Oxide Product Portfolio Table 76. Mallinckrodt Recent Development Table 77. Praxair (Linde plc) Company Information Table 78. Praxair (Linde plc) Business Overview Table 79. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 80. Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio Table 81. Praxair (Linde plc) Recent Development Table 82. Air Liquide Company Information Table 83. Air Liquide Business Overview Table 84. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 85. Air Liquide Inhaled Nitric Oxide Product Portfolio Table 86. Air Liquide Recent Development Table 87. BOC Healthcare (Linde Group) Company Information Table 88. BOC Healthcare (Linde Group) Business Overview Table 89. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 90. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio Table 91. BOC Healthcare (Linde Group) Recent Development Table 92. North America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (M L): 2021 VS 2025 VS 2032 Table 93. North America Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 94. North America Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 95. North America Inhaled Nitric Oxide Sales Forecast by Country (2027-2032) & (M L) Table 96. North America Inhaled Nitric Oxide Sales Market Share Forecast by Country (2027-2032) Table 97. North America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Inhaled Nitric Oxide Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Inhaled Nitric Oxide Market Share by Country (2021-2026) Table 100. North America Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Inhaled Nitric Oxide Market Share Forecast by Country (2027-2032) Table 102. Europe Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (M L): 2021 VS 2025 VS 2032 Table 103. Europe Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 104. Europe Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 105. Europe Inhaled Nitric Oxide Sales Forecast by Country (2027-2032) & (M L) Table 106. Europe Inhaled Nitric Oxide Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Inhaled Nitric Oxide Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Inhaled Nitric Oxide Market Share by Country (2021-2026) Table 110. Europe Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Inhaled Nitric Oxide Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (M L): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 114. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Inhaled Nitric Oxide Sales Forecast by Country (2027-2032) & (M L) Table 116. Asia-Pacific Inhaled Nitric Oxide Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Inhaled Nitric Oxide Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Inhaled Nitric Oxide Market Share by Country (2021-2026) Table 120. Asia-Pacific Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Inhaled Nitric Oxide Market Share Forecast by Country (2027-2032) Table 122. Latin America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (M L): 2021 VS 2025 VS 2032 Table 123. Latin America Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 124. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 125. Latin America Inhaled Nitric Oxide Sales Forecast by Country (2027-2032) & (M L) Table 126. Latin America Inhaled Nitric Oxide Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Inhaled Nitric Oxide Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Inhaled Nitric Oxide Market Share by Country (2021-2026) Table 130. Latin America Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Inhaled Nitric Oxide Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (M L): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 134. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Inhaled Nitric Oxide Sales Forecast by Country (2027-2032) & (M L) Table 136. Middle East and Africa Inhaled Nitric Oxide Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Inhaled Nitric Oxide Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Inhaled Nitric Oxide Market Share by Country (2021-2026) Table 140. Middle East and Africa Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Inhaled Nitric Oxide Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Inhaled Nitric Oxide Distributors List Table 145. Inhaled Nitric Oxide Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Image Figure 2. Global Inhaled Nitric Oxide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled Nitric Oxide Sales (2021-2032) & (M L) Figure 5. 800 ppm Image Figure 6. Global 800 ppm Sales YoY Growth (2021-2032) & (M L) Figure 7. 100 ppm Image Figure 8. Global 100 ppm Sales YoY Growth (2021-2032) & (M L) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M L) Figure 11. Global Inhaled Nitric Oxide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Inhaled Nitric Oxide Market Share by Type 2025 VS 2032 Figure 13. North America Inhaled Nitric Oxide Sales Market Share in Volume by Type in 2025 Figure 14. North America Inhaled Nitric Oxide Sales Market Share in Value by Type in 2025 Figure 15. Europe Inhaled Nitric Oxide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Inhaled Nitric Oxide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Inhaled Nitric Oxide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Inhaled Nitric Oxide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Inhaled Nitric Oxide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Inhaled Nitric Oxide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Inhaled Nitric Oxide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Inhaled Nitric Oxide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Inhaled Nitric Oxide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Near-term and Pre-term Infants PPHN Image Figure 26. Global Near-term and Pre-term Infants PPHN Sales YoY Growth (2021-2032) & (M L) Figure 27. Children and Adult ARDS Image Figure 28. Global Children and Adult ARDS Sales YoY Growth (2021-2032) & (M L) Figure 29. Other Diseases Image Figure 30. Global Other Diseases Sales YoY Growth (2021-2032) & (M L) Figure 31. Global Inhaled Nitric Oxide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Inhaled Nitric Oxide Market Share by Application 2025 VS 2032 Figure 33. North America Inhaled Nitric Oxide Sales Market Share in Volume by Application in 2025 Figure 34. North America Inhaled Nitric Oxide Sales Market Share in Value by Application in 2025 Figure 35. Europe Inhaled Nitric Oxide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Inhaled Nitric Oxide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Inhaled Nitric Oxide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Inhaled Nitric Oxide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Inhaled Nitric Oxide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Inhaled Nitric Oxide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Inhaled Nitric Oxide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Inhaled Nitric Oxide Sales Market Share in Value by Application in 2025 Figure 43. North America Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Figure 44. North America Inhaled Nitric Oxide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Inhaled Nitric Oxide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Inhaled Nitric Oxide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Figure 48. Europe Inhaled Nitric Oxide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Inhaled Nitric Oxide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Inhaled Nitric Oxide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Figure 52. Asia-Pacific Inhaled Nitric Oxide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Inhaled Nitric Oxide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Inhaled Nitric Oxide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Figure 56. Latin America Inhaled Nitric Oxide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Inhaled Nitric Oxide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Inhaled Nitric Oxide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Figure 60. Middle East and Africa Inhaled Nitric Oxide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Inhaled Nitric Oxide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Inhaled Nitric Oxide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Inhaled Nitric Oxide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
Companies covered
  • Mallinckrodt
  • Praxair (Linde plc)
  • Air Liquide
  • BOC Healthcare (Linde Group)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhaled Nitric Oxide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhaled Nitric Oxide Market by Type
  6. 1.3.1 800 ppm
  7. 1.3.2 100 ppm
  8. 1.3.3 Others
  9. 1.4 Global Inhaled Nitric Oxide Market Size by Type
  10. 1.4.1 Global Inhaled Nitric Oxide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Inhaled Nitric Oxide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Inhaled Nitric Oxide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Inhaled Nitric Oxide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Inhaled Nitric Oxide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Inhaled Nitric Oxide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Inhaled Nitric Oxide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Inhaled Nitric Oxide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Industry Trends
  2. 2.2 Inhaled Nitric Oxide Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhaled Nitric Oxide Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhaled Nitric Oxide Sales (2021-2026)
  3. 3.3 Global Top Players by Inhaled Nitric Oxide Price (2021-2026)
  4. 3.4 Global Inhaled Nitric Oxide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaled Nitric Oxide Major Company Production Sites & Headquarters
  6. 3.6 Global Inhaled Nitric Oxide Company, Product Type & Application
  7. 3.7 Global Inhaled Nitric Oxide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaled Nitric Oxide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaled Nitric Oxide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaled Nitric Oxide Tier 1, Tier 2, and Tier 3
4 Inhaled Nitric Oxide Regional Status and Outlook
  1. 4.1 Global Inhaled Nitric Oxide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhaled Nitric Oxide Historic Market Size by Region
  3. 4.2.1 Global Inhaled Nitric Oxide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhaled Nitric Oxide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhaled Nitric Oxide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhaled Nitric Oxide Forecasted Market Size by Region
  7. 4.3.1 Global Inhaled Nitric Oxide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhaled Nitric Oxide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhaled Nitric Oxide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhaled Nitric Oxide by Application
  1. 5.1 Inhaled Nitric Oxide Market by Application
  2. 5.1.1 Near-term and Pre-term Infants PPHN
  3. 5.1.2 Children and Adult ARDS
  4. 5.1.3 Other Diseases
  5. 5.2 Global Inhaled Nitric Oxide Market Size by Application
  6. 5.2.1 Global Inhaled Nitric Oxide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inhaled Nitric Oxide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inhaled Nitric Oxide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inhaled Nitric Oxide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inhaled Nitric Oxide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inhaled Nitric Oxide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inhaled Nitric Oxide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inhaled Nitric Oxide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mallinckrodt
  2. 6.1.1 Mallinckrodt Company Information
  3. 6.1.2 Mallinckrodt Business Overview
  4. 6.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
  6. 6.1.5 Mallinckrodt Recent Developments
  7. 6.2 Praxair (Linde plc)
  8. 6.2.1 Praxair (Linde plc) Company Information
  9. 6.2.2 Praxair (Linde plc) Business Overview
  10. 6.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
  12. 6.2.5 Praxair (Linde plc) Recent Developments
  13. 6.3 Air Liquide
  14. 6.3.1 Air Liquide Company Information
  15. 6.3.2 Air Liquide Business Overview
  16. 6.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Air Liquide Inhaled Nitric Oxide Product Portfolio
  18. 6.3.5 Air Liquide Recent Developments
  19. 6.4 BOC Healthcare (Linde Group)
  20. 6.4.1 BOC Healthcare (Linde Group) Company Information
  21. 6.4.2 BOC Healthcare (Linde Group) Business Overview
  22. 6.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
  24. 6.4.5 BOC Healthcare (Linde Group) Recent Developments
7 North America by Country
  1. 7.1 North America Inhaled Nitric Oxide Sales by Country
  2. 7.1.1 North America Inhaled Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhaled Nitric Oxide Sales by Country (2021-2026)
  4. 7.1.3 North America Inhaled Nitric Oxide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhaled Nitric Oxide Market Size by Country
  6. 7.2.1 North America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhaled Nitric Oxide Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhaled Nitric Oxide Sales by Country
  2. 8.1.1 Europe Inhaled Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhaled Nitric Oxide Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhaled Nitric Oxide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhaled Nitric Oxide Market Size by Country
  6. 8.2.1 Europe Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhaled Nitric Oxide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhaled Nitric Oxide Sales by Country
  2. 9.1.1 Asia-Pacific Inhaled Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhaled Nitric Oxide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhaled Nitric Oxide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhaled Nitric Oxide Market Size by Country
  6. 9.2.1 Asia-Pacific Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhaled Nitric Oxide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhaled Nitric Oxide Sales by Country
  2. 10.1.1 South America Inhaled Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhaled Nitric Oxide Sales by Country (2021-2026)
  4. 10.1.3 South America Inhaled Nitric Oxide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhaled Nitric Oxide Market Size by Country
  6. 10.2.1 South America Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhaled Nitric Oxide Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country
  2. 11.1.1 Middle East and Africa Inhaled Nitric Oxide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhaled Nitric Oxide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhaled Nitric Oxide Market Size by Country
  6. 11.2.1 Middle East and Africa Inhaled Nitric Oxide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhaled Nitric Oxide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhaled Nitric Oxide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhaled Nitric Oxide Value Chain Analysis
  2. 12.1.1 Inhaled Nitric Oxide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhaled Nitric Oxide Production Mode & Process
  7. 12.2 Inhaled Nitric Oxide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhaled Nitric Oxide Distributors
  10. 12.2.3 Inhaled Nitric Oxide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst